BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4076329)

  • 1. Protein binding and disposition of lignocaine in the elderly.
    Cusack B; O'Malley K; Lavan J; Noel J; Kelly JG
    Eur J Clin Pharmacol; 1985; 29(3):323-9. PubMed ID: 4076329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibition.
    Bax ND; Tucker GT; Lennard MS; Woods HF
    Br J Clin Pharmacol; 1985 May; 19(5):597-603. PubMed ID: 2860914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
    Bax ND; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1980 Oct; 10(4):353-61. PubMed ID: 7448106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of lignocaine on plasma protein binding and pharmacokinetics of verapamil in dogs.
    Belpaire FM; De Rick A; Bourda A; De Smet F; Rosseel MT; Bogaert MG
    J Pharm Pharmacol; 1990 Jan; 42(1):45-9. PubMed ID: 1969949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lignocaine kinetics in cardiac patients and aged subjects.
    Nation RL; Triggs EJ; Selig M
    Br J Clin Pharmacol; 1977 Aug; 4(4):439-48. PubMed ID: 901735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A free lignocaine index as a guide to unbound drug concentration.
    Routledge PA; Lazar JD; Barchowsky A; Stargel WW; Wagner GS; Shand DG
    Br J Clin Pharmacol; 1985 Dec; 20(6):695-8. PubMed ID: 4092000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the role of alpha 1-acid glycoprotein in lignocaine accumulation following myocardial infarction.
    Barchowsky A; Shand DG; Stargel WW; Wagner GS; Routledge PA
    Br J Clin Pharmacol; 1982 Mar; 13(3):411-5. PubMed ID: 7059443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lignocaine disposition in blood in epilepsy.
    Routledge PA; Stargel WW; Finn AL; Barchowsky A; Shand DG
    Br J Clin Pharmacol; 1981 Nov; 12(5):663-6. PubMed ID: 7332731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: lidocaine and indocyanine green.
    Williams RL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
    Clin Pharmacol Ther; 1976 Sep; 20(3):290-9. PubMed ID: 954351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.
    Nattel S; Gagne G; Pineau M
    Clin Pharmacokinet; 1987 Nov; 13(5):293-316. PubMed ID: 2891461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-related differences in the plasma protein binding of lignocaine and diazepam.
    Routledge PA; Stargel WW; Kitchell BB; Barchowsky A; Shand DG
    Br J Clin Pharmacol; 1981 Mar; 11(3):245-50. PubMed ID: 7213526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of ranitidine on the disposition of lignocaine.
    Robson RA; Wing LM; Miners JO; Lillywhite KJ; Birkett DJ
    Br J Clin Pharmacol; 1985 Aug; 20(2):170-3. PubMed ID: 4041336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function.
    Orlando R; Piccoli P; De Martin S; Padrini R; Palatini P
    Br J Clin Pharmacol; 2003 Jan; 55(1):86-93. PubMed ID: 12534644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of 'therapeutic' doses of beta-adrenoceptor antagonists to alter the disposition of tolbutamide and lignocaine.
    Miners JO; Wing LM; Lillywhite KJ; Smith KJ
    Br J Clin Pharmacol; 1984 Dec; 18(6):853-60. PubMed ID: 6152176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of propranolol and pindolol on plasma lignocaine clearance in man.
    Svendsen TL; Tangø M; Waldorff S; Steiness E; Trap-Jensen J
    Br J Clin Pharmacol; 1982; 13(Suppl 2):223S-226S. PubMed ID: 7104144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of drug protein binding and alpha 1-acid glycoprotein concentration in Chinese and Caucasians.
    Feely J; Grimm T
    Br J Clin Pharmacol; 1991 May; 31(5):551-2. PubMed ID: 1888624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of age and smoking on the plasma protein binding of lignocaine and diazepam.
    Davis D; Grossman SH; Kitchell BB; Shand DG; Routledge PA
    Br J Clin Pharmacol; 1985 Feb; 19(2):261-5. PubMed ID: 3986083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of lignocaine in children following caudal anaesthesia.
    Ecoffey C; Desparmet J; Berdeaux A; Maury M; Giudicelli JF; Saint-Maurice C
    Br J Anaesth; 1984 Dec; 56(12):1399-402. PubMed ID: 6498050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme-inducing drugs.
    Perucca E; Hedges A; Makki KA; Richens A
    Br J Clin Pharmacol; 1980 Nov; 10(5):491-7. PubMed ID: 7437261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of lidocaine clearance in elderly male subjects.
    Abernethy DR; Greenblatt DJ
    J Cardiovasc Pharmacol; 1983; 5(6):1093-6. PubMed ID: 6196560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.